Beijing Konruns Pharmaceutical Co Ltd (603590) — Capital Reinvestment Ratio
Beijing Konruns Pharmaceutical Co Ltd (603590) has a Capital Reinvestment Ratio of 0.18x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥96.44 Million) in capital expenditures (CN¥17.27 Million). See 603590 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beijing Konruns Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Beijing Konruns Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 13 annual periods. Check Beijing Konruns Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Beijing Konruns Pharmaceutical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Beijing Konruns Pharmaceutical Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see market value of Beijing Konruns Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.46x | CN¥115.68 Million | CN¥53.45 Million | ▼ -23.5% |
| 2024 | 0.60x | CN¥172.25 Million | CN¥104.02 Million | ▲ +19.3% |
| 2023 | 0.51x | CN¥199.35 Million | CN¥100.91 Million | ▼ -37.1% |
| 2022 | 0.80x | CN¥119.69 Million | CN¥96.31 Million | ▼ -65.3% |
| 2021 | 2.32x | CN¥70.91 Million | CN¥164.65 Million | ▲ +169.2% |
| 2020 | 0.86x | CN¥58.41 Million | CN¥50.37 Million | ▲ +1096.5% |
| 2019 | 0.07x | CN¥262.00 Million | CN¥18.89 Million | ▲ +12.6% |
| 2018 | 0.06x | CN¥263.11 Million | CN¥16.85 Million | ▼ -48.7% |
| 2017 | 0.12x | CN¥270.49 Million | CN¥33.73 Million | ▼ -89.7% |
| 2016 | 1.21x | CN¥148.26 Million | CN¥178.67 Million | ▲ +412.6% |
| 2015 | 0.24x | CN¥191.80 Million | CN¥45.09 Million | ▼ -10.0% |
| 2014 | 0.26x | CN¥130.98 Million | CN¥34.20 Million | ▼ -26.5% |
| 2013 | 0.36x | CN¥163.72 Million | CN¥58.17 Million | — |